MD839G2 - Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi metodă de normalizare a stării fiziologice a omului şi animalelor - Google Patents

Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi metodă de normalizare a stării fiziologice a omului şi animalelor

Info

Publication number
MD839G2
MD839G2 MD95-0377A MD950377A MD839G2 MD 839 G2 MD839 G2 MD 839G2 MD 950377 A MD950377 A MD 950377A MD 839 G2 MD839 G2 MD 839G2
Authority
MD
Moldova
Prior art keywords
baa
animal tissue
obtaining
biologically active
base
Prior art date
Application number
MD95-0377A
Other languages
English (en)
Romanian (ro)
Russian (ru)
Other versions
MD839F1 (en
Inventor
Alexandr Nicolaenco
Original Assignee
Alexandr Nicolaenco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SU5063049 external-priority patent/RU2041715C1/ru
Application filed by Alexandr Nicolaenco filed Critical Alexandr Nicolaenco
Priority claimed from PCT/UA1993/000003 external-priority patent/WO1994002104A1/ru
Publication of MD839F1 publication Critical patent/MD839F1/xx
Publication of MD839G2 publication Critical patent/MD839G2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
MD95-0377A 1992-07-21 1993-07-20 Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi metodă de normalizare a stării fiziologice a omului şi animalelor MD839G2 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SU5063049 RU2041715C1 (ru) 1992-07-21 1992-07-21 Биологически активное средство, способ его получения, препарат, содержащий указанное средство, и способ использования препарата
UA93030288A UA2164C2 (uk) 1992-07-21 1992-12-17 Біологічноактивний засіб, що має імуномодулюючу властивість, спосіб його одержання, препарат на його основі та спосіб нормалізації фізіологічного стану організму людини та тварин при захворюваннях, що породжені переважно патологічно зміненими і/або чужерідними клітинами, мікроорганізмами і/або продуктами їх життєдіяльності, із використанням такого препарату
PCT/UA1993/000003 WO1994002104A1 (fr) 1992-07-21 1993-07-20 Agent biologiquement actif ayant des proprietes d'immunomodulation, procede pour sa production et preparation pharmaceutique a base de cet agent

Publications (2)

Publication Number Publication Date
MD839F1 MD839F1 (en) 1997-09-30
MD839G2 true MD839G2 (ro) 1998-05-31

Family

ID=26666279

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0377A MD839G2 (ro) 1992-07-21 1993-07-20 Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi metodă de normalizare a stării fiziologice a omului şi animalelor

Country Status (9)

Country Link
EP (1) EP0673652B1 (de)
AT (1) ATE214283T1 (de)
AU (1) AU4767693A (de)
BG (1) BG61680B1 (de)
CA (1) CA2149146A1 (de)
DE (1) DE69331704T2 (de)
HU (1) HUT73378A (de)
MD (1) MD839G2 (de)
PL (1) PL173321B1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116844160B (zh) * 2023-09-01 2023-11-28 武汉互创联合科技有限公司 基于主体识别的胚胎发育质量评估系统

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU139404A1 (ru) * 1960-12-10 1961-11-30 Н.Г. Беленький Способ производства тканевых препаратов
FR2413912A1 (fr) * 1978-01-10 1979-08-03 Bontemps Raymond Medicaments a base de substances d'origine foetale et leur procede preparation
SU904707A1 (ru) * 1979-06-25 1982-02-15 Ленинградский Ветеринарный Институт Средство дл повышени резистентности организма молодн ка животных и способ его получени
US4455302A (en) * 1973-10-24 1984-06-19 Robertson Harry J Medical protein hydrolysate, process of making the same and processes of utilizing the protein hydrolysate to aid in healing traumatized areas
EP0249563A1 (de) * 1986-06-12 1987-12-16 Gérard Laumond Tierische Embryoorgangewebeextrakte, verwendbar als Mittel zum Stimulieren menschlicher, organischer, metabolischer Funktionen
SU1442064A3 (ru) * 1983-10-05 1988-11-30 Золько Базель Аг, (Фирма) Способ получени экстракта, обладающего иммуномодулирующим действием, из животного сырь

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56501525A (de) * 1979-11-22 1981-10-22
DE3276616D1 (en) * 1982-01-11 1987-07-30 Theurer Karl Eugen Products for intravasal application of water-soluble or emulsifiable antigenic organ extracts
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU139404A1 (ru) * 1960-12-10 1961-11-30 Н.Г. Беленький Способ производства тканевых препаратов
US4455302A (en) * 1973-10-24 1984-06-19 Robertson Harry J Medical protein hydrolysate, process of making the same and processes of utilizing the protein hydrolysate to aid in healing traumatized areas
FR2413912A1 (fr) * 1978-01-10 1979-08-03 Bontemps Raymond Medicaments a base de substances d'origine foetale et leur procede preparation
SU904707A1 (ru) * 1979-06-25 1982-02-15 Ленинградский Ветеринарный Институт Средство дл повышени резистентности организма молодн ка животных и способ его получени
SU1442064A3 (ru) * 1983-10-05 1988-11-30 Золько Базель Аг, (Фирма) Способ получени экстракта, обладающего иммуномодулирующим действием, из животного сырь
EP0249563A1 (de) * 1986-06-12 1987-12-16 Gérard Laumond Tierische Embryoorgangewebeextrakte, verwendbar als Mittel zum Stimulieren menschlicher, organischer, metabolischer Funktionen

Also Published As

Publication number Publication date
DE69331704T2 (de) 2002-10-31
CA2149146A1 (en) 1994-02-03
AU4767693A (en) 1994-02-14
PL173321B1 (pl) 1998-02-27
BG99446A (bg) 1996-03-29
ATE214283T1 (de) 2002-03-15
DE69331704D1 (de) 2002-04-18
EP0673652B1 (de) 2002-03-13
EP0673652A1 (de) 1995-09-27
MD839F1 (en) 1997-09-30
EP0673652A4 (de) 1996-07-03
HUT73378A (en) 1996-07-29
PL308535A1 (en) 1995-08-21
HU9500410D0 (en) 1995-04-28
BG61680B1 (bg) 1998-03-31

Similar Documents

Publication Publication Date Title
CN105395467B (zh) 一种中药组合物、美肤化妆品及其应用
ATE277638T1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
EP3156065A1 (de) Hydrolysierte fibroinhaltige salbe und herstellungsverfahren dafür
DE68912589T2 (de) Mittel zur verbesserung des fettabbaus und verfahren zur verwendung.
RU2110984C1 (ru) Косметический марикрем для ухода за кожей
WO2001049822A3 (en) Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy
CN101180034A (zh) 毛发护理制剂
MD839G2 (ro) Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi metodă de normalizare a stării fiziologice a omului şi animalelor
KR20120130180A (ko) 미생물의 포자화에 수반하는 모세포 분해효소를 이용한 유기물의 분해방법
CN108635253A (zh) 一种婴幼儿蛋黄油化妆品
CN113648336A (zh) 一种基于蜂蜜与积雪草外泌体的制备提取方法
JP3413220B2 (ja) 肌荒れ改善剤
CN101283956A (zh) 胆碱酯酶在治疗或改善皮肤症状的皮肤护理用品中的应用
MD838G2 (ro) Remediu biologic activ cu proprietate imunomodulatoare, procedeu de obţinere a lui, preparat pe baza lui şi procedeu de normalizare a stării fiziologice a omului şi animalelor
RU2070409C1 (ru) Препарат для лечения мастита у лактирующих животных
CN113855595A (zh) 一种具备生物活性的抗衰老冻干粉制剂
US2187766A (en) Therapeutic composition
CN120983523B (zh) 一种宠物应激舒缓剂
HARTLEY et al. Experimental osteogenesis in rabbit muscle
RU2235548C1 (ru) Ранозаживляющее средство
DE69118796T2 (de) Vernarbungsfördernde pharmazeutische Verbindung
CN109674672A (zh) 一种头皮护理组合物及其应用
DE4236064C2 (de) Selektiv-toxisches Mittel und seine Verwendung
EP0164423A3 (de) Träger- und Begleitstoffe für biologische Wirk - und Regulationsfaktoren aus Zellen und Geweben und deren Anwendung
CN112807419A (zh) 一种药物组合物及其制备方法、外用药和应用

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20130720

KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees